Evidence map›Paper›PMID 18658120›Full record

ArticleRNA (New York, N.Y.)2008

A glimpse into the active site of a group II intron and maybe the spliceosome, too.

Kwaku T Dayie, Richard A Padgett

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. The ChloroplastCells · 2021
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Model systems: how chemical biologists study RNA.Current opinion in chemical biology · 2009
    Review
  19. Structural insights into RNA splicing.Current opinion in structural biology · 2009
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kwaku T DayieDepartment of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Richard A Padgett

Funding

Structure of a ribozyme catalytic centerR01GM077326 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI DAYIE, KWAKU · 2007 to 2011
$1.4M
Mechanism of U12-dependent spliceosomal splicingR01GM079527 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI PADGETT, RICHARD A · 2007 to 2010
$1.2M
NIGMS NIH HHS GM079527NIGMS NIH HHS GM77326NIGMS NIH HHS R01 GM077326NIGMS NIH HHS R01 GM079527
6 · The paper itself

Abstract

The X-ray crystal structure of an excised group II self-splicing intron was recently solved by the Pyle group. Here we review some of the notable features of this structure and what they may tell us about the catalytic active site of the group II ribozyme and potentially the spliceosome. The new structure validates the central role of domain V in both the structure and catalytic function of the ribozyme and resolves several outstanding puzzles raised by previous biochemical, genetic and structural studies. While lacking both exons as well as the cleavage sites and nucleophiles, the structure reveals how a network of tertiary interactions can position two divalent metal ions in a configuration that is ideal for catalysis.

Indexed as

Alternative SplicingIntronsBinding SitesCatalytic DomainCrystallography, X-RayIonsMetalsNucleic Acid ConformationRNA, CatalyticSpliceosomesIonsMetalsRNA, Catalytic

Identifiers

PMID18658120
PMCPMC2525965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.